HYULIM A-TECH Co., Ltd. Stock

Equities

A078590

KR7078590007

Auto, Truck & Motorcycle Parts

End-of-day quote Korea S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
848 KRW +0.36% Intraday chart for HYULIM A-TECH Co., Ltd. -0.47% -29.33%
Sales 2019 64.6B 47.03M Sales 2020 61.41B 44.7M Capitalization 404B 294M
Net income 2019 -6.05B -4.4M Net income 2020 -180B -131M EV / Sales 2019 1.21 x
Net cash position 2019 7.67B 5.59M Net Debt 2020 4B 2.91M EV / Sales 2020 6.64 x
P/E ratio 2019
-13.5 x
P/E ratio 2020
-2.09 x
Employees 94
Yield 2019 *
-
Yield 2020
-
Free-Float 52.94%
More Fundamentals * Assessed data
Dynamic Chart
DIAC Co., Ltd. acquired Automotive division of CANARIABIO M Inc. CI
Diac to Raise $7.8 Million via Share Issuance MT
DIAC Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Hyulim ROBOT Co.,Ltd. CI
OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer CI
OncoQuest Pharmaceuticals Inc. completed the spin-off of OQP BIO Inc. CI
OncoQuest Pharmaceuticals Inc. completed the spin-off of Dual Moolsan Holdings Co., Ltd. CI
Quest PharmaTech Inc. Announces Two Presentations by Oncoquest Pharmaceuticals, Inc. At the 2021 Annual Meeting of the American Association of Clinical Oncologists CI
The Board of Directors of OncoQuest Pharmaceuticals Inc. announced to spin off Manufacturing Management Division. CI
The Board of Directors of OncoQuest Pharmaceuticals Inc. announced to spin-off biotechnology division. CI
OncoQuest Pharmaceuticals Inc.(KOSDAQ:A078590) dropped from S&P Global BMI Index CI
OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational Drug, Oregovomab, in Frontline Ovarian Cancer CI
OncoQuest Pharmaceuticals, Inc. Appoints Dr. Sunil Gupta as Chief Medical Officer CI
DUAL Industrial Co., Ltd's Equity Buyback announced on March 25, 2020, has expired. CI
OncoQuest Pharmaceuticals Inc.(KOSDAQ:A078590) added to S&P Global BMI Index CI
DUAL Industrial Co., Ltd. announced that it has received KRW 20 billion in funding CI
More news
1 day+0.36%
1 week-0.47%
Current month-10.17%
1 month-20.23%
3 months-22.38%
6 months-14.13%
Current year-29.33%
More quotes
1 week
837.00
Extreme 837
867.00
1 month
837.00
Extreme 837
1 130.00
Current year
837.00
Extreme 837
1 695.00
1 year
837.00
Extreme 837
2 975.00
3 years
837.00
Extreme 837
2 975.00
5 years
837.00
Extreme 837
18 425.00
10 years
837.00
Extreme 837
18 425.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 19-03-04
Chief Tech/Sci/R&D Officer - 20-11-08
Director/Board Member 59 -
Members of the board TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member 62 -
More insiders
Date Price Change Volume
24-04-24 848 +0.36% 167,968
24-04-23 845 -0.35% 132,540
24-04-22 848 -0.47% 275,343
24-04-19 852 -1.73% 264,810
24-04-18 867 +1.76% 293,901

End-of-day quote Korea S.E., April 23, 2024

More quotes
Hyulim A-Tech Co Ltd, formerly Diac Co Ltd, is a Korea-based company mainly engaged in the manufacture and sale of automobile parts. The Company is engaged in the manufacture and sale of interior materials including carpets and trunk trims, as well as exterior materials such as wheel guards and under covers. Additionally, the Company is engaged in the manufacture of automobiles and trailers.
More about the company
  1. Stock Market
  2. Equities
  3. A078590 Stock